ImpriMed uses artificial intelligence to predict the effectiveness of anticancer drugs for dogs with lymphoma or leukemia. By analyzing live cancer cells, they provide personalized treatment options, helping veterinarians choose the most effective chemotherapy for each dog.
Trending Companies
Latest Articles
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.